Biocon sees a sweet spot with its affordable insulin in US
The biotech firm is also planning to provide its rh-insulin to middle- and low-income countries at less than 10 cents a day. Biocon Biologics is chasing a revenue target of $1 billion in financial year 2021-22. In the previous fiscal year, its revenue had topped $200 million.
Fact-check: Diabetes is killing Indians; control your weight, diet to delay condition
By 2030, the number of people expected to suffer from T...
Volume with low cost is Biocon Biologics’ big plan
The Biocon subsidiary will chart a path that ensures high volumes and low costs, unlike co...
Get treated for sleep apnea: It can cause blindness in diabetic patients
Diabetic macular edema is more difficult to treat in patients with severe sleep apnea.
Are you exercising enough? Lack of physical activity may up early death risk in adults
Physical activity is known to reduce deaths from heart disease and diabetes.
Parliamentary panel recommends integration of Indian Systems of Medicine with modern treatment
The Department-related Parliamentary Standing Committee on Health and Family Welfare, in its 115th report submitted in Rajya Sabha on Wednesday, said an earlier document had recognized the need to build capacity of existing human resource in the health care sector to address the shortage of healthcare professionals.
Diabetes health insurance is expensive. Here's a 4-point guide to manage related costs
Diabetes-specific plans are expensive. The downside of generic health plans is the longer waiting period. Besides the price it exacts on your health, diabetes also places enormous strain on finances. Find out ways to mitigate the financial burden.
Nutrition survey finds rising diabetes risk in children
One percent of school-age children and adolescents were diabetic and three percent of school-age children and four per cent of adolescents had high total cholesterol.
Medical marvel: New AI system can accurately detect diabetic retinopathy
The screening system can provide a reading in just 60 seconds.
What is Sleeveballoon? New device that can treat Type 2 diabetes, obesity
Sleeveballoon is a device that combines a balloon with a connected sleeve.
Belly fat bringing you down? Lower risk of age-related diseases by burning it
The human body's ability to generate energy by burning the belly fat reduces with age.
Making innovation a way of life
Product innovation is relatively easier because it concerns only a few employees in the company. Simply put, it refers to a change in an existing product, in terms of physical appearance or performance. So, it could be an additional camera on a phone or a revamped dashboard in an automobile.
Dealing with type-2 diabetes? Weight loss during the first five years may help you recover
Type 2 diabetes affects 400 million people worldwide and increases the risk of heart disease.
Macleods Pharma USA Inc recalls 31,968 bottles of diabetes drug in US
Macleods Pharma USA Inc has declared Pioglitazone Hydrochloride tablets used for treatment of diabetes in America to be superpotent which was manufactured in Baddi, Himachal Pradesh. The product was shipped to 8 distributors in US, USFDA reported.
Copyright © 2020 Bennett, Coleman & Co. Ltd. All rights reserved. For reprint rights: Times Syndication Service